ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66 | -99.9% | 3,087 | -47.4% | 0.00% | – |
| Q3 2022 | $113,000 | 0.0% | 5,865 | +3.0% | 0.00% | – |
| Q2 2022 | $113,000 | +334.6% | 5,694 | +406.1% | 0.00% | – |
| Q4 2021 | $26,000 | -10.3% | 1,125 | +34.7% | 0.00% | – |
| Q3 2021 | $29,000 | 0.0% | 835 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -74.3% | 835 | -74.2% | 0.00% | – |
| Q1 2021 | $113,000 | +438.1% | 3,234 | +477.5% | 0.00% | – |
| Q4 2020 | $21,000 | -97.7% | 560 | -98.0% | 0.00% | -100.0% |
| Q3 2020 | $919,000 | +371.3% | 27,543 | +274.1% | 0.00% | – |
| Q2 2020 | $195,000 | +126.7% | 7,363 | +39.8% | 0.00% | – |
| Q1 2020 | $86,000 | +1620.0% | 5,265 | +2150.0% | 0.00% | – |
| Q4 2019 | $5,000 | -90.7% | 234 | -91.4% | 0.00% | – |
| Q3 2019 | $54,000 | +285.7% | 2,716 | +521.5% | 0.00% | – |
| Q1 2019 | $14,000 | 0.0% | 437 | -26.1% | 0.00% | – |
| Q4 2018 | $14,000 | – | 591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 330,407 | $5,409,000 | 2.53% |
| Perceptive Advisors | 1,960,139 | $31,931,000 | 0.83% |
| Birchview Capital, LP | 48,000 | $786,000 | 0.70% |
| Chicago Capital, LLC | 492,878 | $8,068,000 | 0.65% |
| Artal Group S.A. | 588,125 | $9,628,000 | 0.41% |
| PA Capital LLC | 23,198 | $380,000 | 0.34% |
| Eversept Partners, LP | 78,029 | $1,277,335 | 0.32% |
| HEARTLAND ADVISORS INC | 150,000 | $2,456,000 | 0.26% |
| ArrowMark Colorado Holdings LLC | 972,372 | $15,918,000 | 0.21% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 25,268 | $414,000 | 0.14% |